Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Mohammadreza, Bozorgmanesh ^a   Farzad, Hadaegh ^a   Davoud, Khalili ^a   Prof, Azizi F ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Cardiovascular disease; Prediction; Visceral adiposity index; Waist to height ratio; Waist to hip ratio

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; LIPID; ORAL ANTIDIABETIC AGENT; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ADULT; ALGORITHM; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; IRAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE; VISCERA; VISCERAL ADIPOSITY; VISCERAL ADIPOSITY INDEX; WAIST HIP RATIO; BLOOD; BODY HEIGHT; CHI SQUARE DISTRIBUTION; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OBESITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL; TIME; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ALGORITHMS; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRA-ABDOMINAL FAT; IRAN; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84862315932     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-20     Document Type: Article

References (36)

1. Litwin SE. Which Measures of Obesity Best Predict Cardiovascular Risk?. J Am Coll Cardiol 2008, 52:616-619. 10.1016/j.jacc.2008.05.017, 18702963.
2. Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, Harris TB, Everhart JE, Schenker N. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. American Journal of Clinical Nutrition 2009, 89:500. 10.3945/ajcn.2008.26847, 2647766, 19116329.
3. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A. Group ftAS: Visceral Adiposity Index. Diabetes Care 2010, 33:920-922. 10.2337/dc09-1825, 2845052, 20067971.
4. Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010, 9:45. 10.1186/1476-511X-9-45, 2876156, 20459710.
5. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 2010, 9:100. 10.1186/1476-511X-9-100, 2949857, 20846382.
6. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5. 2656492, 19166627.
7. Freedman DS, Kahn HS, Mei Z, Grummer-Strawn LM, Dietz WH, Srinivasan SR, Berenson GS. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 2007, 86:33-40.
8. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006, 13:571-577. 10.1097/01.hjr.0000216552.81882.ca, 16874147.
9. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003, 107:149-158. 10.1161/01.CIR.0000047041.66447.29, 12515758.
10. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al. ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction-2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002, 106:1893-1900. 10.1161/01.CIR.0000037106.76139.53, 12356647.
11. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
12. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
13. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study. International Journal of Clinical Practice 2011, 65:264-273. 10.1111/j.1742-1241.2010.02529.x, 21314863.
14. Abbate LM, Stevens J, Schwartz TA, Renner JB, Helmick CG, Jordan JM. Anthropometric measures, body composition, body fat distribution, and knee osteoarthritis in women. Obesity (Silver Spring) 2006, 14:1274-1281.
15. D'Agostino RB, Nam BH. Evaluation of the performance of survival analysis models: Discrimination and Calibration measures. Handbook of Statistics, Survival Methods 2004, 23:1-25. Amsterdam, The Netherlands: Elsevier B.V., Balakrishnan N, Rao CR.
16. Hosmer DW, Lemeshow S. Applied logistic regression 2000, Wiley-Interscience.
17. Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data 2008, Hoboken, N.J.: Wiley-Interscience, 2.
18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
19. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
20. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, Go AS, Harrell FE, Hong Y, Howard BV, et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association. Circulation 2009, 119:2408-2416. 10.1161/CIRCULATIONAHA.109.192278, 2956982, 19364974.
21. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-112, 10.1002/sim.2929, 17569110.
22. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002, 324:1570-1576. 10.1136/bmj.324.7353.1570, 1123506, 12089098.
23. Rose G. The strategy of preventive medicine. Rose&# 39; Strategy of Preventive Medicine 2008, 1:33-35.
24. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids in Health and Disease 2011, 10:183. 10.1186/1476-511X-10-183, 3224548, 22011564.
25. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of Obesity and Cardiovascular Risk Among Men and Women. J Am Coll Cardiol 2008, 52:605-615. 10.1016/j.jacc.2008.03.066, 2671389, 18702962.
26. Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovasc Diabetol 2011, 10:20. 10.1186/1475-2840-10-20, 3056766, 21356116.
27. Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB, Yanez ND, Gelaye B, Williams MA. Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults 2011, 2011. Journal of Hypertension: International.
28. Dong X, Liu Y, Yang J, Sun Y, Chen L. Efficiency of anthropometric indicators of obesity for identifying cardiovascular risk factors in a Chinese population. Postgraduate Medical Journal
29. Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MSV, Paik MC. Improving Global Vascular Risk Prediction With Behavioral and Anthropometric Factors: The Multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol 2009, 54:2303-2311. 10.1016/j.jacc.2009.07.047, 2812026, 19958966.
30. Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, Dorr M, Felix S, Lehnert H, Pittrow D, et al. The Predictive Value of Different Measures of Obesity for Incident Cardiovascular Events and Mortality. J Clin Endocrinol Metab 2010, 95:1777-1785. 10.1210/jc.2009-1584, 20130075.
31. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond) 2009, 33:1437-1445.
32. Despres JP. Is visceral obesity the cause of the metabolic syndrome?. Ann Med 2006, 38:52-63. 10.1080/07853890500383895, 16448989.
33. Lebovitz HE, Banerji MA. Point: Visceral Adiposity Is Causally Related to Insulin Resistance. Diabetes Care 2005, 28:2322-2325. 10.2337/diacare.28.9.2322, 16123512.
34. Kramer CK, von Muhlen D, Gross JL, Barrett-Connor E. A Prospective Study of Abdominal Obesity and Coronary Artery Calcium Progression in Older Adults. J Clin Endocrinol Metab 2009, 94:5039-5044. 10.1210/jc.2009-1497, 2795663, 19846732.
35. Gutin B, Johnson MH, Humphries MC, Hatfield-Laube JL, Kapuku GK, Allison JD, Gower BA, Daniels SR, Barbeau P. Relationship of Visceral Adiposity to Cardiovascular Disease Risk Factors in Black and White Teens[ast]. Obesity 2007, 15:1029-1035. 10.1038/oby.2007.602, 17426339.
36. Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P, Wasem J, Jöckel KH. Age-and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome-A cross-sectional study. Cardiovasc Diabetol 2010, 9:34. 10.1186/1475-2840-9-34, 2929217, 20696055.